PAVmed Inc.
No enriched coverage for $PAVM in the last 7 days.
No SEC Form 4 filings for $PAVM in the last 30 days.
PAVmed Inc. (PAVM) is projected to report a loss of 70 cents per share in its upcoming earnings announcement. This information comes from a Refinitiv earnings preview. The article is very brief and provides no additional details.
PAVmed Inc. has registered 9,230,786 shares of common stock for resale by existing stockholders, including shares issued from the conversion of Series D preferred stock and shares issuable from related warrants. The company will not receive proceeds from these resales, but could receive up to $30 million if the warrants are exercised. This registration allows selling stockholders to sell shares on public markets, subject to various market conditions and limitations.
Scott V. Dols has reported a beneficial ownership of 346,155 shares, representing a 5.4% stake in PAVmed Inc. (NASDAQ: PAVM). This disclosure was made via a Schedule 13G SEC filing, based on 6,383,089 shares outstanding as of March 27, 2026. Dols holds sole voting and dispositive power over these shares, which include 230,770 shares held in a trust where he serves as trustee.
